Company: RNAC
Filing Date: 2025-08-07
Form Type: 8-K
Source: 0001453687-25-000098
Chunk: 1

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-08-07
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Exhibit Description                                                          
      No.                                                                                   
     99.1      Press release of Cartesian Therapeutics, Inc. issued on A ugust 7, 2025.     
 ────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  CARTESIAN THERAPEUTICS, INC.                                             
  By:                               /s/ Carsten Brunn, Ph. D.              
                                    Carsten Brunn, Ph. D.                  
                                    President and Chief Executive Officer